Vitality Watch

Dossier clinicaltrials trial early 30-jul-2026
Small or early-phase human trial or pilot study

Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors

Key claim: A phase II trial is testing whether fisetin plus exercise can prevent frailty in breast cancer survivors by clearing senescent cells.

Abstract

This phase II trial tests how well fisetin and exercise works in preventing frailty in breast cancer survivors. Fisetin is a natural substance found in strawberries and other foods and is available as a nutritional supplement. Nutritional supplements may be useful in eliminating cells that have undergone a process called senescence. Senescence is when a cell ages and permanently stops dividing but does not die. Over time, large numbers of these cells build up in tissues throughout the body and can release harmful substances that cause inflammation and damage nearby healthy cells. Giving fisetin may eliminate senescent cells in patients with breast cancer undergoing physical activity.

Why this matters

Cancer survivors carry an elevated senescent-cell burden from chemotherapy and radiation, making them a high-yield population for testing whether senolytics translate mechanism into clinical frailty prevention. Pairing fisetin with exercise probes whether a natural senolytic can augment a proven physical-function intervention, or whether exercise alone accounts for any benefit — a design contrast that has been missing from most early senolytic trials. Until readout, this is a registered probe, not evidence that fisetin prevents frailty.

Source

Link

Briefing card

Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
Stage: trial early · clinicaltrials · 30-jul-2026

If you are a breast cancer survivor considering fisetin for post-treatment frailty, this trial is testing that exact question — results are not yet available.

A phase II trial is testing whether fisetin plus exercise can prevent frailty in breast cancer survivors by clearing senescent cells.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06113016

build build 880 · 2bcef25 · 2026-11-18